Epithelial-Mesenchymal Transition

Core Idea

Epithelial-mesenchymal transition (EMT) is a cellular program in which polarized epithelial cells lose their cell-cell adhesions, apical-basal polarity, and epithelial gene expression, and gain migratory, invasive, mesenchymal properties. EMT is driven by transcription factors (Snail, Slug, Twist, ZEB1/2) that repress E-cadherin and activate mesenchymal genes like vimentin and N-cadherin. EMT occurs during normal development (gastrulation, neural crest delamination, heart valve formation) and is pathologically reactivated during cancer metastasis, where it enables tumor cells to invade surrounding tissues and enter the bloodstream. The reverse process (MET, mesenchymal-epithelial transition) is equally important in development and in metastatic colonization.

Explainer

Epithelial tissues are defined by their organization: cells are tightly connected to each other through adherens junctions, tight junctions, and desmosomes, forming continuous sheets with defined apical (top) and basal (bottom) surfaces. This organization is essential for barrier function (skin, gut lining) and secretion (glands). Mesenchymal cells, by contrast, are loosely organized, embedded in extracellular matrix, and capable of individual migration. The epithelial-mesenchymal transition is the cellular program that converts one into the other — and it is one of the most consequential processes in both normal development and disease.

During development, EMT occurs at several critical moments. At gastrulation, cells that will form mesoderm and endoderm undergo EMT to leave the epithelial epiblast and migrate into the interior of the embryo. During neural crest delamination, cells at the border of the neural plate undergo EMT to become the migratory neural crest population. In heart development, endocardial cells undergo EMT to form the cardiac cushions that will become heart valves. In each case, the molecular mechanism involves activation of EMT transcription factors (Snail, Slug, Twist, ZEB1, ZEB2) by developmental signaling pathways (TGF-beta, Wnt, FGF, Notch). These transcription factors repress E-cadherin and other epithelial genes while activating mesenchymal genes (vimentin, N-cadherin, matrix metalloproteinases).

The reverse process, MET (mesenchymal-epithelial transition), is equally important. After neural crest cells reach their destinations, some undergo MET to form epithelial structures (like dorsal root ganglia). During kidney development, metanephric mesenchyme undergoes MET to form the epithelial nephron tubules. MET involves the reactivation of E-cadherin expression, re-establishment of cell-cell junctions and polarity, and suppression of mesenchymal genes. The ability to switch between epithelial and mesenchymal states — epithelial plasticity — is a fundamental property that enables the morphogenetic flexibility required during development.

In cancer, EMT is pathologically reactivated. Tumor cells at the invasive front of epithelial cancers often show reduced E-cadherin, increased vimentin, and nuclear localization of EMT transcription factors. These cells have acquired the ability to detach from the primary tumor, invade surrounding tissue, enter blood vessels, and survive in circulation — the early steps of metastasis. Recent work has shown that the most dangerous metastatic cells may not undergo full EMT but rather exist in partial EMT states, retaining some epithelial adhesion (enabling collective migration and clusters in circulation, which have higher metastatic efficiency than individual cells) while gaining enough mesenchymal character to invade. At distant sites, successful metastatic cells undergo MET to proliferate and form secondary tumors. This dynamic epithelial-mesenchymal plasticity, not a one-way EMT, drives the metastatic process.